Abstract
Theiler's murine encephalomyelitis virus (TMEV) induces an acute polioencephalomyelitis and a chronic demyelinating leukomyelitis in SJL mice. C57BL/6 (B6) mice generally do not develop TMEV-induced demyelinating disease (TMEV-IDD) due to virus elimination. However, TMEV can persist in specific immunodeficient B6 mice such as IFNβ−/− mice and induce a demyelinating process. The proinflammatory cytokines IL-1β and IL-18 are activated by the inflammasome pathway, which consists of a pattern recognition receptor molecule sensing microbial pathogens, the adaptor molecule Apoptosis-associated speck-like protein containing a CARD (ASC), and the executioner caspase-1. To analyze the contribution of the inflammasome pathway to the resistance of B6 mice to TMEV-IDD, ASC- and caspase-1-deficient mice and wild type littermates were infected with TMEV and investigated using histology, immunohistochemistry, RT-qPCR, and Western Blot. Despite the antiviral activity of the inflammasome pathway, ASC- and caspase-1-deficient mice eliminated the virus and did not develop TMEV-IDD. Moreover, a similar IFNβ and cytokine gene expression was found in the brain of immunodeficient mice and their wild type littermates. Most importantly, Western Blot showed cleavage of IL-1β and IL-18 in all investigated mice. Consequently, inflammasome-dependent activation of IL-1β and IL-18 does not play a major role in the resistance of B6 mice to TMEV-IDD.
Similar content being viewed by others
Introduction
Theiler's murine encephalomyelitis virus (TMEV) is a single-stranded RNA virus of the Picornaviridae family1. The intracerebral infection of SJL mice with TO subgroup strains of TMEV (BeAn, DA) induces a biphasic disease characterized by acute polioencephalomyelitis and chronic demyelinating leukomyelitis, which represents an important animal model of human multiple sclerosis (MS)2,3,4. TMEV-induced demyelinating disease (TMEV-IDD) is initiated by oligodendrocyte apoptosis and axonal damage and aggravated by a delayed-type hypersensitivity response directed against viral antigens and later myelin components5,6,7. The virus mainly infects hippocampal and cortical neurons in the early phase of the disease but only persists in white matter glial cells and macrophages in advanced stages8. In contrast to SJL mice, C57BL/6 (B6) mice eliminate the virus from the central nervous system (CNS) within few weeks and do not develop TMEV-IDD9,10. Nevertheless, TMEV can persist in specific immunodeficient B6 mice such as interferon (IFN)-β knockout mice and even induce demyelination in their spinal cord11.
The proinflammatory cytokines IL-1β and IL-18 are produced as inactive precursors (Pro-IL-1β and Pro-IL-18), which are processed by caspase-1 and caspase-4/5/11 after activation of the inflammasome pathway12,13,14,15,16,17. Inflammasomes are vital players in innate immunity and involved in the complex host–pathogen-interactions. Typical inflammasomes represent multiprotein complexes composed of a pathogen sensor molecule such as nucleotide binding domain and leucine-rich repeat-containing receptor (NLR) or AIM2-like receptor (ALR), the adaptor molecule apoptosis-associated speck-like protein containing a caspase activation and recruitment domain (ASC) and the executioner caspase-118,19,20,21. These molecules are mainly expressed by microglia in the brain but astrocytes and neurons as well as myeloid cells infiltrating from the periphery can produce and activate inflammasome pathway components22,23. Inflammasome activation prevents viral replication by inducing an inflammatory cell death program termed pyroptosis mediated by the pore-forming protein gasdermin D (GSDMD)18,24,25. Moreover, the inflammasome pathway has an indirect antiviral effect due to the inhibition of the immunosuppressive effects of type I IFN (IFN-I) on T cells26,27. Correspondingly, the NLRP3 inflammasome pathway is critical for the control of West Nile virus (WNV) infections, because it inhibits WNV replication in neurons28,29. Nonetheless, wild type and caspase-1-deficient mice are equally susceptible to encephalomyocarditis virus (EMCV) and vesicular stomatitis virus (VSV) infection despite the ability of the NLRP3 inflammasome to detect these viruses30. Interestingly, the promotion of T cell pathogenicity and CNS cell infiltration caused by inflammasome signaling contributes to the development of MS lesions31. Moreover, the inhibition of NLRP3 inflammasome activation by IFN-I plays a major role in the response of MS patients to IFNβ treatment32,33. Likewise, the NLRP3 inflammasome can induce demyelinating lesions in experimental autoimmune encephalomyelitis (EAE), an animal model of MS, because it aggravates the infiltration of inflammatory immune cells into the CNS32. Nevertheless, EAE can even be induced in Nlrp3−/− and Asc−/− mice by an aggressive immunization using a myelin oligodendrocyte glycoprotein peptide in complete Freund’s adjuvant with 300 mg of heat-killed Mycobacteria. Similar to MS, the administration of IFNβ usually ameliorates EAE but in such NLRP3 inflammasome-independent EAE this treatment is not effective34. Asc−/− mice develop milder EAE lesions compared to Casp1−/− mice due to inflammasome-independent functions of ASC, which support the survival of CD4+ T cells including myelin oligodendrocyte glycoprotein–specific T cells35. ASC also regulates the activity of the mitogen-activated protein kinase (MAPK) extracellular-signal regulated kinase (ERK) in murine and human monocytes/macrophages, antigen-specific IgG responses and chemokine and IFN-I expression independent of inflammasome activation28,36,37. Consequently, the different inflammasome pathway components can independently control inflammatory processes.
ASC increases serum levels of IFNα, IFNγ, IL-1β, IL-6, CCL2, CCL5, CXCL1, and immunoglobulin M (IgM) during WNV infection thereby limiting viral replication. Nevertheless, elevated and not reduced levels of IFNγ, CCL2 and CCL5 were found in the brains from WNV-infected Asc−/− mice correlating with enhanced astrocyte activation, leukocyte infiltration and neuronal cell death28. Strong activation of the NLRP3 inflammasome and down-stream PGE2 signaling in dendritic cells and CD11b+ leukocytes, spleen cells and bone marrow cells of SJL mice also impairs early protective IFNγ-producing CD4+ and CD8+ T cell responses allowing viral persistence necessary for TMEV-IDD38. The exact role of specific inflammasome pathway components in the pathogenesis of TMEV-IDD has not been investigated so far. Therefore, the present study aimed to analyze the consequences of ASC or caspase-1 deficiency on virus elimination, CNS inflammation, and clinical outcome in TMEV-infected B6 mice. Moreover, the cytokine and IFN-I expression was analyzed in detail at 4 days post infection (dpi) due to the high number of T cells and B cells as well as peak of viral load in the brain of TMEV-infected B6 mice at this time point39,40,41.
Results
Clinical and histological investigation
Clinical signs were absent in all investigated mice after TMEV infection. Moreover, mice continuously gained weight during the investigation period and their motor coordination did not deteriorate (Fig. 1A,B). Asc−/− and Casp1−/− mice developed mild to moderate inflammatory brain and spinal cord lesions in the acute phase of the disease (4 and 14 dpi), which did not differ significantly from their wild type littermates (Fig. 1C–E). In the chronic phase of the disease (98 dpi) perivascular mononuclear cell infiltrates were also found in the spinal cord of Asc−/− and Casp1−/− mice as well as brain of Asc−/− mice but not in the brain of Casp1−/− mice (Fig. 1C,D). To illustrate a productive virus infection leading to demyelinating lesions in susceptible SJL but not in resistant B6 mice, clinical, histological, and RT-qPCR data of TMEV- and mock-infected SJL and B6 mice are summarized in Fig. 2.
Immunohistochemistry
TMEV+ cells were mainly detected at 4 dpi in all investigated mouse groups (Fig. 3A,B). Virus antigen was only present in few cells of single animals at 14 dpi and not found at 98 dpi. The perivascular mononuclear cell infiltrates contained approximately 70% CD3+ T cells, 10% CD45R+ B cells and 20% Iba-1+ macrophages (Fig. 3C). No significant differences between Asc−/− and Casp1−/− mice and their respective wild type littermates were found in the composition of these leukocytes in the perivascular area.
RT-qPCR
RT-qPCR did not reveal significant differences in the amount of TMEV RNA as well as Ifnb1, Isg15, Eif2ak1 (PKR), Tnfa, Il1a, Il1b, Il6, Il10, Il12 (p40) and Ifng transcript numbers in the brain of Asc−/− and Casp1−/− mice and their respective wild type littermates at 4 days after TMEV infection (Fig. 4). No Il17 mRNA was found in the brain of these mice at this time point.
Western Blot
Western blot analysis confirmed the expression of IL-1β and IL-18 proteins in the brain of TMEV-infected mice and wild type littermates at 4 dpi. Moreover, activation/cleavage of the precursor forms of these proinflammatory cytokines (Pro-IL-1β and Pro-IL-18) into the mature proteins was demonstrated in Casp1+/+, Casp1−/−, Asc+/+ and Asc−/− mice as well as TMEV- and mock-infected SJL and B6 mice (Fig. 5, Suppl. Figure 1).
Discussion
ASC and caspase-1 are major components of the inflammasome pathway, which plays a critical role in several neuroinflammatory and neurodegenerative diseases including MS17,22,31,42. Inflammasome activation induces the maturation of the proinflammatory cytokines IL-1β, IL-18, and IL-33 by proteolytic cleavage of their precursor forms. IL-1β is involved in the acute phase response and stimulates the expression of adhesion molecules on endothelial cells and chemokines necessary for leukocyte recruitment. IL-1β also orchestrates the differentiation and function of innate and adaptive lymphoid cells43. For instance, the induction of eicosanoids such as PGE2 by IL-1β limits immunosuppressive effects of IFN-I on T cell functions26,44. IL-18 has been implicated in several autoimmune diseases including MS, because it stimulates γδ T cells to express IL-17 and promotes the production of the Th1 cytokine IFNγ from T cells and NK cells45. IL-33 is a potent inducer for a Th2 immune response, but this IL-1-like cytokine is inactivated after maturation by caspase-146,47.
However, the present study revealed no consequences of ASC or caspase-1 deficiency on virus elimination, CNS inflammation, cytokine and IFN-I expression and clinical outcome in TMEV-infected B6 mice. In contrast, the infection of immunodeficient IFN-β knockout mice (also B6 background) with the same virus strain and dosage resulted in virus persistence, increased cytokine expression and mild inflammatory demyelinating spinal cord lesions11. Lack of inflammasome-dependent IL-1β maturation might have been compensated by increased expression of IL-1α, which can be upregulated in TMEV-infected astrocytes and bind to the same receptor48,49,50. Nonetheless, no significant differences in Il1a mRNA levels were found between ASC- and caspase-1-deficient mice and their wild type littermates. Moreover, Tnfa, Il6, Il10, Il12, and Ifng mRNA levels were similar in all investigated mice at 4 dpi indicating that ASC- and caspase-1-deficiency does not influence cytokine expression in the brain of TMEV-infected B6 mice significantly.
Interestingly, Western blot analysis demonstrated the activation/cleavage of IL-1β and IL-18 proteins in both knockout mouse strains, which can be explained by alternative inflammasome-independent pathways of IL-1β and IL-18 maturation. In addition to microorganisms such as Candida albicans, Staphylococcus aureus and Streptococcus pyogenes, monocyte/macrophages, neutrophils, NK cells, mast cells and epithelial cells can produce proteases able to cleave pro-IL-1β including the serine proteases proteinase 3, cathepsin G, elastase, granzyme A, chymase, chymotrypsin as well as the metalloproteinases Meprin α and Meprin β16,51. Correspondingly, an increased expression of cathepsins and granzymes, which are released by monocytes/macrophages and NK cells respectively, has been described in the brain and spinal cord of TMEV-infected mice6,52. Consequently, the production of different serine proteases by NK cells and microglia/macrophages likely compensates lack of inflammasome-dependent regulation of IL-1-family cytokines during TMEV infection.
In conclusion, ASC or caspase-1 deficiency had no effect on virus elimination, CNS inflammation, IFN-I and cytokine gene expression and clinical outcome in TMEV-infected B6 mice. The present results demonstrate that inflammasome-dependent pathways do not play a major role in the resistance of B6 mice to TMEV-IDD due to the activity of other proteases able to cleave IL-1β, IL-18, and IL-33. Nevertheless, future studies are needed to unravel the complex interactions of the inflammasome and other proinflammatory pathways in neuroinflammatory diseases.
Materials and methods
Animal experiment
Asc−/− (B6.129S5-Pycardtm1Flv) mice (http://www.informatics.jax.org/allele/MGI:3686870) and Casp1−/− (Casp1tm2.1Flv) were generated as described53,54,55,56. Briefly, Asc and Casp1 targeting vectors were electroporated into 129SvEvBrd Lex-1 and JM8 C57BL/6 embryonic stem cells, respectively. Offspring was backcrossed to B6 mice. Heterozygous knockout mice were used to breed 27 Asc−/− and 28 Casp1−/− mice and 60 wild type littermates. SJL/J and B6 mice were obtained from Harlan Winkelmann (now Envigo RMS GmbH, Düsseldorf, Germany). Mice were kept under controlled environmental conditions (22–24 °C; 50–60% humidity; 12/12 h light/dark cycle) with free access to standard rodent diet (R/M-H; sniff Spezialdiäten GmbH, Soest, Germany) and tap water. At the age of five to six weeks, groups of seven to ten knockout mice and wild type littermates were inoculated into the right cerebral hemisphere with 1 × 105 plaque-forming units (PFU) per mouse of the BeAn strain of TMEV in 20 µl Dulbecco’s modified Eagle medium (DMEM; PAA Laboratories, Cölbe, Germany) with 2% fetal calf serum and 50 μg/kg gentamicin. This virus stock and dose has been used in several publications and is known to induce TMEV-IDD in SJL mice and in B6 mice11,39,57,58,59,60. To illustrate a productive viral infection and disease course, data of additional experiments using SJL and B6 mice infected with TMEV-BeAn (1.63 × 106 PFU) or mock-infected with DMEM were included in the study. Inoculation was performed under general anesthesia using an intraperitoneal injection of medetomidine (0.5 mg/kg, Domitor; 50 µl for a mouse of 20 g; Pfizer, Karlsruhe, Germany) and ketamine (100 mg/kg, Ketamin 10%; 100 µl for a mouse of 20 g; WDT eG, Garbsen, Germany). General appearance, activity, and gait was evaluated weekly as previously described61. Moreover, a rotarod assay (RotaRod Treadmill, TSE Technical & Scientific Equipment, Bad Homburg, Germany) was performed every week to test motor strength and control of TMEV-infected mice62. Animals were sacrificed at 4, 14 and 98 dpi using an intraperitoneal injection of an overdose of medetomidine (1 mg/kg, Domitor; 20 µl for a mouse of 20 g; Pfizer) and ketamine (200 mg/kg, Ketamin 10%; 40 µl for a mouse of 20 g; WDT eG). Segments of the brain and spinal cord of mice were removed immediately after death and either formalin-fixed and paraffin-embedded or snap-frozen in OCT embedding compound (Sakura Finetek Europe, Zoeterwoude, Netherlands) using liquid nitrogen63. Animal experiments were conducted in accordance with the German Animal Welfare Law and the ARRIVE guidelines64 and were authorized by the local government (Niedersächsisches Landesamt für Verbraucherschutz und Lebensmittelsicherheit, Oldenburg, Germany, permission numbers: 509c-42502-02/589, 509.6-42502-04/860, 33.12-42502-04-14/1656).
Histological examination
Two micrometers paraffin sections of brain (cerebrum and cerebellum) and spinal cord (cervical, thoracic and lumbar) were routinely stained with hematoxylin and eosin (HE). The degree of inflammation was evaluated in two complete cross sections of the brain at the levels of the hippocampus and cerebellum and complete cross sections of the cervical, thoracic and lumbar spinal cord using a semiquantitative scoring system of perivascular mononuclear cell infiltrates (0 = normal, 1 = single inflammatory cells, 2 = 2–3 layers of infiltrates, 3 = more than 3 layers of infiltrates surrounding meningeal and parenchymal vessels) after blinding6,10,61,65.
Immunohistochemistry
Immunohistochemistry was performed as previously described6,10,66,67,68. Briefly, paraffin sections were blocked with 20% goat serum and stained with rabbit polyclonal antibodies directed against TMEV antigen (VP1; 1:2000), CD3 (T lymphocytes; Agilent Technologies Deutschland GmbH, Waldbronn, Germany; A045201; 1:500) and Iba-1 (microglia/macrophages; Wako Chemicals GmbH, Neuss, Germany; 019-19741; 1:1000) or rat monoclonal antibody directed against CD45R (B lymphocytes; BD Biosciences, Heidelberg, Germany; clone RA3-6B2; 553085; 1:1000) overnight at 4 °C. Primary antibodies were replaced by rabbit serum (R4505, Merck KGaA, Darmstadt, Germany) or rat serum (R9759; Merck KGaA) as negative control. Biotinylated goat-anti-rabbit IgG (BA-1000, Vector Laboratories, Burlingame, CA, USA; 1:200) and rabbit-anti rat IgG (BA-4001; Vector Laboratories; 1:200) were used as secondary antibodies. Immunolabeling was visualized by the avidin–biotin-peroxidase complex (ABC) method (PK-6100, Vector Laboratories) with 3,3-diaminobenzidine (DAB, Merck KGaA) as substrate and slight counterstaining was performed using Mayer’s hematoxylin. Percentages of perivascular CD3+ T cells, CD45R+ B cells and Iba-1+ macrophages were determined by randomly counting 100 cells in the Virchow-Robin space of vessels present in one cross section of the cerebrum at the level of the hippocampus. Moreover, all TMEV+ cells were counted in a serial section at this level.
Polymerase chain reaction
RNA has been isolated from a complete cross section of the OCT-embedded cerebrum at the level of the hippocampus. Real-time quantitative polymerase chain reaction (RT-qPCR) was performed for TMEV, Ifnb1, Isg15, Eif2ak1, Tnfa, Il1a, Il1b, Il6, Il10, Il12 (p40), Il17, Ifng and three housekeeping genes (Actb, Gadph, Hprt1) using standard protocols, the AriaMx Real-Time PCR system (Agilent Technologies Deutschland GmbH), and Brilliant III Ultra-Fast SYBR® QPCR Master Mixes as described49,66,68,69. Tenfold serial dilution standards were used to quantify the results. Experimental data were normalized using a normalization factor calculated from the three housekeeping genes70. Specificity of each reaction was controlled by melting curve analysis.
Western blot
Proteins have been isolated from a complete cross section of the OCT-embedded cerebrum at the level of the hippocampus. Cells were lysed in radioimmunoprecipitation assay (RIPA) buffer (1 mM phenylmethylsulfonyl fluoride, 1% sodium deoxycholate, 50 mM Tris–HCl [pH 7.4], 1% Triton X-100, 0.1% SDS, 150 mM NaCl) with added protease inhibitor cocktail (cOmplete, EDTA free; Roche Diagnostics GmbH, Mannheim, Germany). The total protein concentration of each sample was determined using the Pierce™ BCA™ Protein-Assay (Thermo Fisher, Rockford, IL, USA) according to the manufacture’s instructions. 20 µg of total protein were separated by SDS–polyacrylamide gel electrophoresis followed by transfer to polyvinylidene difluoride (PVDF) membranes (Novex™). Rabbit polyclonal antibodies were used to detect IL-1β (P420B; Thermo Fisher; 1:1000), IL-18 (PA5-79481; Thermo Fisher; 1:1000), and Laminin (PA5-19468; Thermo Fisher; 1:1000). Then, blots were incubated with a peroxidase-coupled goat anti-rabbit secondary antiserum (32460; Thermo Fisher; 1:500) and the binding was visualized using SuperSignal™ West Femto Maximum Sensitivity Substrate (34095; Thermo Fisher) and a ChemiDoc™ MP Imaging System (BioRad). For band size determination PageRuler™ Plus Prestained Protein Ladder (10 to 250 kDa; 26620; Thermo Fisher) was used.
Statistical analysis
Statistical analysis was performed using Prism 6 (GraphPad Software, La Jolla, CA, USA). Mann–Whitney tests were used to compare clinical, histological, immunohistochemical and PCR data (knockout vs. wild type mice). P < 0.05 was considered as statistical significant.
Data availability
The datasets generated and analyzed during the current study can be obtained from the corresponding author on reasonable request.
References
Theiler, M. Spontaneous encephalomyelitis of mice, a new virus disease. J. Exp. Med. 65, 705–719 (1937).
Mecha, M., Carrillo-Salinas, F. J., Mestre, L., Feliu, A. & Guaza, C. Viral models of multiple sclerosis: Neurodegeneration and demyelination in mice infected with Theiler’s virus. Prog. Neurobiol. 101–102, 46–64. https://doi.org/10.1016/j.pneurobio.2012.11.003 (2013).
Oleszak, E. L., Chang, J. R., Friedman, H., Katsetos, C. D. & Platsoucas, C. D. Theiler’s virus infection: A model for multiple sclerosis. Clin. Microbiol. Rev. 17, 174–207 (2004).
Tsunoda, I. et al. Three immune-mediated disease models induced by Theiler’s virus: Multiple sclerosis, seizures and myocarditis. Clin. Exp. Neuroimmunol. 7, 330–345. https://doi.org/10.1111/cen3.12341 (2016).
Tsunoda, I. & Fujinami, R. S. Neuropathogenesis of Theiler’s murine encephalomyelitis virus infection, an animal model for multiple sclerosis. J. Neuroimmune Pharmacol. 5, 355–369. https://doi.org/10.1007/s11481-009-9179-x (2010).
Gerhauser, I. et al. Dynamic changes and molecular analysis of cell death in the spinal cord of SJL mice infected with the BeAn strain of Theiler’s murine encephalomyelitis virus. Apoptosis 23, 170–186. https://doi.org/10.1007/s10495-018-1448-9 (2018).
Miller, S. D. et al. Persistent infection with Theiler’s virus leads to CNS autoimmunity via epitope spreading. Nat. Med. 3, 1133–1136 (1997).
Gerhauser, I., Hansmann, F., Ciurkiewicz, M., Löscher, W. & Beineke, A. Facets of Theiler’s murine encephalomyelitis virus-induced diseases: An update. Int. J. Mol. Sci. 20, E448. https://doi.org/10.3390/ijms20020448 (2019).
Lipton, H. L. & Dal Canto, M. C. Susceptibility of inbred mice to chronic central nervous system infection by Theiler’s murine encephalomyelitis virus. Infect. Immun. 26, 369–374 (1979).
Gerhauser, I., Alldinger, S. & Baumgärtner, W. Ets-1 represents a pivotal transcription factor for viral clearance, inflammation, and demyelination in a mouse model of multiple sclerosis. J. Neuroimmunol. 188, 86–94. https://doi.org/10.1016/j.jneuroim.2007.05.019 (2007).
Bühler, M. et al. IFN-beta deficiency results in fatal or demyelinating disease in C57BL/6 mice infected with Theiler’s murine encephalomyelitis viruses. Front. Immunol. 13, 786940. https://doi.org/10.3389/fimmu.2022.786940 (2022).
Thornberry, N. A. et al. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 356, 768–774. https://doi.org/10.1038/356768a0 (1992).
Kostura, M. J. et al. Identification of a monocyte specific pre-interleukin 1 beta convertase activity. Proc. Natl. Acad. Sci. U.S.A. 86, 5227–5231. https://doi.org/10.1073/pnas.86.14.5227 (1989).
Gu, Y. et al. Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science 275, 206–209. https://doi.org/10.1126/science.275.5297.206 (1997).
Wang, S. et al. Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell 92, 501–509 (1998).
Netea, M. G., van de Veerdonk, F. L., van der Meer, J. W., Dinarello, C. A. & Joosten, L. A. Inflammasome-independent regulation of IL-1-family cytokines. Annu. Rev. Immunol. 33, 49–77. https://doi.org/10.1146/annurev-immunol-032414-112306 (2015).
Singhal, G., Jaehne, E. J., Corrigan, F., Toben, C. & Baune, B. T. Inflammasomes in neuroinflammation and changes in brain function: a focused review. Front. Neurosci. 8, 315. https://doi.org/10.3389/fnins.2014.00315 (2014).
Shrivastava, G., Leon-Juarez, M., Garcia-Cordero, J., Meza-Sanchez, D. E. & Cedillo-Barron, L. Inflammasomes and its importance in viral infections. Immunol. Res. 64, 1101–1117. https://doi.org/10.1007/s12026-016-8873-z (2016).
Chakraborty, S., Kaushik, D. K., Gupta, M. & Basu, A. Inflammasome signaling at the heart of central nervous system pathology. J. Neurosci. Res. 88, 1615–1631. https://doi.org/10.1002/jnr.22343 (2010).
Ransohoff, R. M. & Brown, M. A. Innate immunity in the central nervous system. J. Clin. Invest. 122, 1164–1171. https://doi.org/10.1172/JCI58644 (2012).
Platnich, J. M. & Muruve, D. A. NOD-like receptors and inflammasomes: A review of their canonical and non-canonical signaling pathways. Arch. Biochem. Biophys. 670, 4–14. https://doi.org/10.1016/j.abb.2019.02.008 (2019).
Voet, S., Srinivasan, S., Lamkanfi, M. & van Loo, G. Inflammasomes in neuroinflammatory and neurodegenerative diseases. EMBO Mol. Med. https://doi.org/10.15252/emmm.201810248 (2019).
Olcum, M., Tastan, B., Kiser, C., Genc, S. & Genc, K. Microglial NLRP3 inflammasome activation in multiple sclerosis. Adv. Protein Chem. Struct. Biol. 119, 247–308. https://doi.org/10.1016/bs.apcsb.2019.08.007 (2020).
Shi, J., Gao, W. & Shao, F. Pyroptosis: Gasdermin-mediated programmed necrotic cell death. Trends Biochem. Sci. 42, 245–254. https://doi.org/10.1016/j.tibs.2016.10.004 (2017).
Shi, J. et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526, 660–665. https://doi.org/10.1038/nature15514 (2015).
Kim, B. S. et al. IL-1 signal affects both protection and pathogenesis of virus-induced chronic CNS demyelinating disease. J. Neuroinflammation 9, 217. https://doi.org/10.1186/1742-2094-9-217 (2012).
McRae, B. L., Semnani, R. T., Hayes, M. P. & van Seventer, G. A. Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell development. J. Immunol. 160, 4298–4304 (1998).
Kumar, M. et al. Inflammasome adaptor protein apoptosis-associated speck-like protein containing CARD (ASC) is critical for the immune response and survival in west nile virus encephalitis. J. Virol. 87, 3655–3667. https://doi.org/10.1128/JVI.02667-12 (2013).
Ramos, H. J. et al. IL-1beta signaling promotes CNS-intrinsic immune control of West Nile virus infection. PLoS Pathog. 8, e1003039. https://doi.org/10.1371/journal.ppat.1003039 (2012).
Rajan, J. V., Rodriguez, D., Miao, E. A. & Aderem, A. The NLRP3 inflammasome detects encephalomyocarditis virus and vesicular stomatitis virus infection. J. Virol. 85, 4167–4172. https://doi.org/10.1128/JVI.01687-10 (2011).
Barclay, W. & Shinohara, M. L. Inflammasome activation in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). Brain Pathol. 27, 213–219. https://doi.org/10.1111/bpa.12477 (2017).
Inoue, M. & Shinohara, M. L. The role of interferon-beta in the treatment of multiple sclerosis and experimental autoimmune encephalomyelitis—In the perspective of inflammasomes. Immunology 139, 11–18. https://doi.org/10.1111/imm.12081 (2013).
Malhotra, S. et al. NLRP3 inflammasome is associated with the response to IFN-beta in patients with multiple sclerosis. Brain 138, 644–652. https://doi.org/10.1093/brain/awu388 (2015).
Inoue, M. et al. Interferon-beta therapy against EAE is effective only when development of the disease depends on the NLRP3 inflammasome. Sci. Signal 5, ra38. https://doi.org/10.1126/scisignal.2002767 (2012).
Shaw, P. J. et al. Cutting edge: critical role for PYCARD/ASC in the development of experimental autoimmune encephalomyelitis. J. Immunol. 184, 4610–4614. https://doi.org/10.4049/jimmunol.1000217 (2010).
Ellebedy, A. H. et al. Inflammasome-independent role of the apoptosis-associated speck-like protein containing CARD (ASC) in the adjuvant effect of MF59. Proc. Natl. Acad. Sci. U.S.A. 108, 2927–2932. https://doi.org/10.1073/pnas.1012455108 (2011).
Taxman, D. J. et al. The NLR adaptor ASC/PYCARD regulates DUSP10, mitogen-activated protein kinase (MAPK), and chemokine induction independent of the inflammasome. J. Biol. Chem. 286, 19605–19616. https://doi.org/10.1074/jbc.M111.221077 (2011).
Kim, S. J., Jin, Y. H. & Kim, B. S. Prostaglandin E2 produced following infection with Theiler’s virus promotes the pathogenesis of demyelinating disease. PLoS ONE 12, e0176406. https://doi.org/10.1371/journal.pone.0176406 (2017).
Ciurkiewicz, M. et al. Cytotoxic CD8(+) T cell ablation enhances the capacity of regulatory T cells to delay viral elimination in Theiler’s murine encephalomyelitis. Brain Pathol. 28, 349–368. https://doi.org/10.1111/bpa.12518 (2018).
Prajeeth, C. K. et al. Limited role of regulatory T cells during acute Theiler virus-induced encephalitis in resistant C57BL/6 mice. J. Neuroinflammation 11, 180. https://doi.org/10.1186/s12974-014-0180-9 (2014).
Kummerfeld, M. et al. Periventricular demyelination and axonal pathology is associated with subependymal virus spread in a murine model for multiple sclerosis. Intervirology 55, 401–416. https://doi.org/10.1159/000336563 (2012).
Noroozi, S., Meimand, H. A. E., Arababadi, M. K., Nakhaee, N. & Asadikaram, G. The effects of IFN-beta 1a on the expression of inflammasomes and apoptosis-associated speck-like proteins in multiple sclerosis patients. Mol. Neurobiol. 54, 3031–3037. https://doi.org/10.1007/s12035-016-9864-8 (2017).
Garlanda, C., Dinarello, C. A. & Mantovani, A. The interleukin-1 family: Back to the future. Immunity 39, 1003–1018. https://doi.org/10.1016/j.immuni.2013.11.010 (2013).
Mayer-Barber, K. D. et al. Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk. Nature 511, 99–103. https://doi.org/10.1038/nature13489 (2014).
Dinarello, C. A., Novick, D., Kim, S. & Kaplanski, G. Interleukin-18 and IL-18 binding protein. Front. Immunol. 4, 289. https://doi.org/10.3389/fimmu.2013.00289 (2013).
Cayrol, C. & Girard, J. P. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc. Natl. Acad. Sci. U. S. A. 106, 9021–9026. https://doi.org/10.1073/pnas.0812690106 (2009).
Abd Rachman Isnadi, M. F. et al. Critical roles of IL-33/ST2 pathway in neurological disorders. Mediators Inflamm. 2018, 5346413. https://doi.org/10.1155/2018/5346413 (2018).
Rubio, N. & Capa, L. Differential IL-1 synthesis by astrocytes from Theiler’s murine encephalomyelitis virus-susceptible and -resistant strains of mice. Cell. Immunol. 149, 237–247. https://doi.org/10.1006/cimm.1993.1151 (1993).
Gerhauser, I. et al. Theiler’s murine encephalomyelitis virus induced phenotype switch of microglia in vitro. J. Neuroimmunol. 252, 49–55. https://doi.org/10.1016/j.jneuroim.2012.07.018 (2012).
Rubio, N. Demonstration of the presence of an interleukin-1 receptor on the surface of murine astrocytes and its regulation by cytokines and Theiler’s virus. Immunology 82, 178–183 (1994).
Fantuzzi, G. et al. Response to local inflammation of IL-1 beta-converting enzyme- deficient mice. J. Immunol. 158, 1818–1824 (1997).
Ciurkiewicz, M. et al. Transcriptome analysis following neurotropic virus infection reveals faulty innate immunity and delayed antigen presentation in mice susceptible to virus-induced demyelination. Brain Pathol. 31, e13000. https://doi.org/10.1111/bpa.13000 (2021).
Mariathasan, S. et al. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430, 213–218. https://doi.org/10.1038/nature02664 (2004).
Sutterwala, F. S. et al. Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 24, 317–327. https://doi.org/10.1016/j.immuni.2006.02.004 (2006).
Blazejewski, A. J. et al. Microbiota normalization reveals that canonical caspase-1 activation exacerbates chemically induced intestinal inflammation. Cell Rep. 19, 2319–2330. https://doi.org/10.1016/j.celrep.2017.05.058 (2017).
Case, C. L. et al. Caspase-11 stimulates rapid flagellin-independent pyroptosis in response to Legionella pneumophila. Proc. Natl. Acad. Sci. U.S.A. 110, 1851–1856. https://doi.org/10.1073/pnas.1211521110 (2013).
Allnoch, L., Baumgärtner, W. & Hansmann, F. Impact of astrocyte depletion upon inflammation and demyelination in a murine animal model of multiple sclerosis. Int. J. Mol. Sci. https://doi.org/10.3390/ijms20163922 (2019).
Bröer, S. et al. Viral mouse models of multiple sclerosis and epilepsy: Marked differences in neuropathogenesis following infection with two naturally occurring variants of Theiler’s virus BeAn strain. Neurobiol. Dis. 99, 121–132. https://doi.org/10.1016/j.nbd.2016.12.020 (2017).
Bröer, S. et al. Brain inflammation, neurodegeneration and seizure development following picornavirus infection markedly differ among virus and mouse strains and substrains. Exp. Neurol. 279, 57–74. https://doi.org/10.1016/j.expneurol.2016.02.011 (2016).
Uhde, A. K. et al. Viral infection of the central nervous system exacerbates interleukin-10 receptor deficiency-mediated colitis in SJL mice. PLoS ONE 11, e0161883. https://doi.org/10.1371/journal.pone.0161883 (2016).
Ulrich, R. et al. MMP-12, MMP-3, and TIMP-1 are markedly upregulated in chronic demyelinating theiler murine encephalomyelitis. J. Neuropathol. Exp. Neurol. 65, 783–793. https://doi.org/10.1097/01.jnen.0000229990.32795.0d (2006).
Ulrich, R., Kalkuhl, A., Deschl, U. & Baumgärtner, W. Machine learning approach identifies new pathways associated with demyelination in a viral model of multiple sclerosis. J. Cell. Mol. Med. 14, 434–448. https://doi.org/10.1111/j.1582-4934.2008.00646.x (2010).
Markus, S., Failing, K. & Baumgärtner, W. Increased expression of pro-inflammatory cytokines and lack of up-regulation of anti-inflammatory cytokines in early distemper CNS lesions. J. Neuroimmunol. 125, 30–41 (2002).
Percie du Sert, N. et al. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. J. Cereb. Blood Flow Metab. 40, 1769–1777. https://doi.org/10.1177/0271678X20943823 (2020).
Gerhauser, I., Ulrich, R., Alldinger, S. & Baumgärtner, W. Induction of activator protein-1 and nuclear factor-kappaB as a prerequisite for disease development in susceptible SJL/J mice after theiler murine encephalomyelitis. J. Neuropathol. Exp. Neurol. 66, 809–818. https://doi.org/10.1097/nen.0b013e3181461f31 (2007).
Li, L., Ulrich, R., Baumgärtner, W. & Gerhauser, I. Interferon-stimulated genes-essential antiviral effectors implicated in resistance to Theiler’s virus-induced demyelinating disease. J. Neuroinflammation 12, 242. https://doi.org/10.1186/s12974-015-0462-x (2015).
Kummerfeld, M., Meens, J., Haas, L., Baumgärtner, W. & Beineke, A. Generation and characterization of a polyclonal antibody for the detection of Theiler’s murine encephalomyelitis virus by light and electron microscopy. J. Virol. Methods 160, 185–188. https://doi.org/10.1016/j.jviromet.2009.04.030 (2009).
Gerhauser, I., Alldinger, S., Ulrich, R. & Baumgärtner, W. Spatio-temporal expression of immediate early genes in the central nervous system of SJL/J mice. Int. J. Dev. Neurosci. 23, 637–649. https://doi.org/10.1016/j.ijdevneu.2005.06.004 (2005).
Waltl, I. et al. Microglia have a protective role in viral encephalitis-induced seizure development and hippocampal damage. Brain. Behav. Immun. 74, 186–204. https://doi.org/10.1016/j.bbi.2018.09.006 (2018).
Vandesompele, J. et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. https://doi.org/10.1186/gb-2002-3-7-research0034 (2002).
Li, D. Role of programmed cell death and the inflammasome pathway in Theiler's murine encephalomyelitis. PhD thesis, https://elib.tiho-hannover.de/servlets/MCRFileNodeServlet/tiho_derivate_00000806/Lid-ws00000820.pdf (2020).
Acknowledgements
Parts of this article have been included into the PhD thesis of D.L.71. The authors thank Julia Baskas, Petra Grünig, Heike Kanapin, Angela Karl, Christiane Namneck, Caroline Schütz, Friederike Walters, and Danuta Waschke for excellent technical assistance. Asc−/− mice were developed by Millennium Pharmaceuticals, Inc. (Cambridge, MA, USA) and kindly provided by Prof. Richard A. Flavell (Yale University, New Haven, CT, USA). Casp1−/− mice were also kindly provided by Prof. Richard A. Flavell.
Funding
Open Access funding enabled and organized by Projekt DEAL. This work was supported by the Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony. D.L. was funded by the China Scholarship Council (File No. 201606170128). This Open Access publication was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)-491094227 “Open Access Publication Funding” and the University of Veterinary Medicine Hannover, Foundation.
Author information
Authors and Affiliations
Contributions
Conceptualization: W.B., T.S. and I.G.; Data curation: D.L., M.B., S.R. and K.M.; Formal analysis: D.L. and I.G.; Funding acquisition: W.B. and I.G.; Investigation: D.L., M.B., S.R, K.M. and I.G.; Methodology: G.G., K.M., T.S. and I.G.; Project administration: W.B. and I.G.; Resources: G.G., T.S. and W.B.; Supervision: W.B. and I.G.; Validation: G.G. and I.G.; Visualization: D.L. and I.G.; Writing – original draft: D.L.; Writing – review & editing: I.G.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Li, D., Bühler, M., Runft, S. et al. ASC- and caspase-1-deficient C57BL/6 mice do not develop demyelinating disease after infection with Theiler’s murine encephalomyelitis virus. Sci Rep 13, 10960 (2023). https://doi.org/10.1038/s41598-023-38152-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-023-38152-3